BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27399084)

  • 1. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
    Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
    Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
    BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
    Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
    Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
    Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area.
    Zeng Q; Hong MH; Shen LJ; Meng XQ; Guo X; Qian CN; Wu PH; Huang PY
    Oncotarget; 2016 May; 7(20):29708-19. PubMed ID: 27102440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
    Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
    Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
    Sun XS; Liang YJ; Liu SL; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Tang LQ; Mai HQ
    Cancer Res Treat; 2019 Oct; 51(4):1259-1268. PubMed ID: 30653745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
    Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
    Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
    Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
    Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area.
    Jin Y; Cai XY; Cai YC; Cao Y; Xia Q; Tan YT; Jiang WQ; Shi YX
    Eur J Cancer; 2012 Apr; 48(6):882-8. PubMed ID: 22030451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
    Jiang Y; Qu S; Pan X; Huang S; Zhu X
    Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
    Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
    PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.